Russell-Silver Syndrome (RSS) is a rare genetic disorder that is characterized by a variety of physical and developmental abnormalities. It is estimated to affect 1 in 100,000 individuals. The syndrome is caused by a mutation in a gene or genes that are involved in the regulation of growth. Symptoms of RSS include growth delays, low birth weight, small head size, asymmetrical body parts, and distinctive facial features. Although the cause of RSS is unknown, recent advances in genetic research are beginning to unlock the mystery of this syndrome and provide new hope for improved treatments.
Russell-Silver Syndrome (RSS) is a rare genetic disorder that is characterized by a variety of physical and developmental abnormalities. It is estimated to affect 1 in 100,000 individuals. The syndrome is caused by a mutation in a gene or genes that are involved in the regulation of growth. Symptoms of RSS include growth delays, low birth weight, small head size, asymmetrical body parts, and distinctive facial features. These features may include a triangular face, thin upper lip, low-set ears, and a curved fifth finger. Individuals with RSS may also have feeding and swallowing difficulties, heart defects, and other medical problems.
The diagnosis of RSS is based on a combination of clinical features, laboratory tests, and genetic testing. A physical examination is used to assess the presence of physical and developmental features associated with the syndrome. Blood tests can be used to measure hormone levels, such as growth hormone and IGF-1, which are typically low in individuals with RSS. Genetic testing is also used to confirm the diagnosis and to identify the specific genetic mutation that is responsible for the disorder.
Treatment of RSS is aimed at addressing the specific symptoms of the disorder. Growth hormone therapy is often used to help improve growth and development. Other treatments, such as physical and occupational therapy, can help improve motor skills and function. Feeding and swallowing difficulties can be addressed through a variety of interventions, including dietary modifications and the use of specialized feeding devices. Surgery may be needed to correct certain physical abnormalities. In addition, individuals with RSS may benefit from psychological and educational interventions to help them reach their full potential.
Recent advances in genetic research are beginning to unlock the mystery of RSS and provide new hope for improved treatments. Researchers have identified several genes that are associated with the syndrome, including EZH2, ZBTB24, and IGF1R. These genes are involved in the regulation of growth, and mutations in these genes can lead to the physical and developmental features of RSS. In addition, researchers are beginning to understand how these mutations affect the development of the disorder. For example, researchers have identified a specific mutation in the EZH2 gene that is associated with RSS. This mutation leads to an increase in the activity of the gene, which can lead to the growth-related features of the disorder.
Russell-Silver Syndrome is a rare genetic disorder that is characterized by a variety of physical and developmental abnormalities. The cause of RSS is unknown, but recent advances in genetic research are beginning to unlock the mystery of this syndrome and provide new hope for improved treatments. With further research, it is hoped that more effective treatments can be developed to help individuals with RSS reach their full potential.
1.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
2.
The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.
3.
Research identifies nearly 200 potential breast carcinogens in food packaging materials
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma
1.
CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights
2.
Uncovering the Hidden Symptoms of Parathyroid Cancer in Women
3.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
4.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
5.
Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding the causes of anemia in adults beyond nutritional deficiencies
2.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation